Felix Hartlepp, VP Research and Technology, ChromoTek, Germany.
Together with his dedicated team at ChromoTek, Felix Hartlepp develops novel Alpaca-derived single domain antibody (sdAb) tools for biochemistry and cell biology applications. Before joining ChromoTek in 2016, he worked for MorphoSys as a Scientist and Project Team Leader for almost a decade. At MorphoSys, he was responsible for antibody screening, characterization and lead candidate generation in various therapeutic antibody projects.
Felix studied biochemistry at the University of Regensburg, Germany, and at the University of Colorado at Boulder, USA. He did his doctoral thesis about ATP-dependent Chromatin Remodeling in Drosophila in the lab of Prof. Peter Becker at the Ludwig-Maximilians-University in Munich, Germany.